Some findings may link GSK-3 with the disease: first, GSK-3 is associated with schizophrenia susceptibility genes such as Akt1, DISC1, and TRAX (Translin-associated protein X) (Emamian et al., 2004; Freyberg et al., 2010; Lipina et al., 2011; Tan et al., 2012; Weng et al., 2018). This evidence concerns the gene TSNAX and schizophrenia.